Non-vascular Stents Market Analysis By Product [Gastrointestinal (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents), Pulmonary, Urological Stents], And Segment Forecasts, 2014 - 2025

  • ID: 4429669
  • Report
  • 104 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • C. R. Bard, Inc.
  • CONMED Corporation
  • Cook Medical
  • ELLA - CS, s.r.o.
  • Glaukos Corporation
  • HOBBS MEDICAL INC
  • MORE
The global non-vascular stents market is anticipated to reach USD 1.4 billion by 2025, according to a new report. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in adoption of minimally invasive surgeries across the world.

Technological advancements such as development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy(cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per requirement as they offer different features.

Due to high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.

Further Key Findings From the Study Suggest:
  • The urological stents segment held a lucrative market share in 2016 owing to worldwide increase in demand for ureteral, and prostate stents, which can be attributed to the surge in number of kidney transplants, ureteroscopy, ureterorenoscopy, lithotripsy, and schistosomiasis procedures
  • The gastrointestinal stents segment is expected to register highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
  • North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with high prevalence of gastrointestinal cancer in the U.S. & Canada
  • Some of the key players in the market are Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; and Glaukos Corporation
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • C. R. Bard, Inc.
  • CONMED Corporation
  • Cook Medical
  • ELLA - CS, s.r.o.
  • Glaukos Corporation
  • HOBBS MEDICAL INC
  • MORE
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.4.3 Region-based segment share calculation
1.5 List of Secondary Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Non-vascular Stents Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing geriatric population & prevalence of chronic and other diseases
3.1.1.2 Increasing adoption of minimally invasive surgeries
3.1.1.3 Technological developments in non-vascular stents
3.1.1.4 Rising per capita healthcare spending
3.1.2 Market restraint analysis
3.1.2.1 Complications associated with non-vascular stents
3.2 Penetration & growth prospect mapping
3.3 Non-vascular Stents - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.3.1 Market SWOT analysis, by factor (political & legal, economic and technological)
3.3.1.1 Political & legal factors
3.3.1.1.1 Strength
3.3.1.1.2 Weakness
3.3.1.1.3 Opportunity
3.3.1.1.4 Threat
3.3.1.2 Economic factors
3.3.1.2.1 Strength
3.3.1.2.2 Weakness
3.3.1.2.3 Opportunity
3.3.1.2.4 Threat
3.3.1.3 Technological factors
3.3.1.3.1 Strength
3.3.1.3.2 Weakness
3.3.1.3.3 Opportunity
3.3.1.3.4 Threat
3.4 Industry Analysis - Porter’s
3.4.1 Porter’s Five Forces analysis
3.4.1.1 Competitive rivalry
3.4.1.2 Bargaining power of suppliers
3.4.1.3 Bargaining power of buyers
3.4.1.4 Threat of new entrants
3.4.1.5 Threat of substitutes

Chapter 4 Non-vascular Stents Product Estimates & Trend Analysis
4.1 Non-vascular stents market: Product movement analysis
4.2 Gastrointestinal Stents
4.2.1 Gastrointestinal stents market, 2014 - 2025 (USD Million)
4.2.2 Biliary stents market, 2014 - 2025 (USD Million)
4.2.2.1 Biliary stents market, 2014 - 2025 (USD Million)
4.2.3 Duodenal stents market, 2014 - 2025 (USD Million)
4.2.3.1 Duodenal stents market, 2014 - 2025 (USD Million)
4.2.4 Colonic stents market, 2014 - 2025 (USD Million)
4.2.4.1 Colonic stents market, 2014 - 2025 (USD Million)
4.2.5 Pancreatic stents market, 2014 - 2025 (USD Million)
4.2.5.1 Pancreatic stents market, 2014 - 2025 (USD Million)
4.2.6 Esophageal stents market, 2014 - 2025 (USD Million)
4.2.6.1 Esophageal stents market, 2014 - 2025 (USD Million)
4.3 Pulmonary (Airway) Stents
4.3.1 Pulmonary (airway) stents market, 2014 - 2025 (USD Million)
4.3.2 Silicone airway stents market, 2014 - 2025 (USD Million)
4.3.2.1 Silicone airway stents market, 2014 - 2025 (USD Million)
4.3.3 Metallic airway stents market, 2014 - 2025 (USD Million)
4.3.3.1 Metallic airway stents market, 2014 - 2025 (USD Million)
4.4 Urological Stents
4.4.1 Urological stents market, 2014 - 2025 (USD Million)
4.5 Others
4.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 5 Non-vascular Stents Regional Estimates & Trend Analysis, by Product
5.1 Non-vascular stents market share by region, 2016 & 2025
5.2 North America
5.2.1 North America non-vascular stents market, 2014 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. non-vascular stents market, 2014 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada non-vascular stents market, 2014 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe non-vascular stents market, 2014 - 2025 (USD Million)
5.3.2 UK
5.3.2.1 UK non-vascular stents market, 2014 - 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany non-vascular stents market, 2014 - 2025 (USD Million)
5.3.4 France
5.3.4.1 France non-vascular stents market, 2014 - 2025 (USD Million)
5.3.5 Italy
5.3.5.1 Italy non-vascular stents market, 2014 - 2025 (USD Million)
5.3.6 Spain
5.3.6.1 Spain non-vascular stents market, 2014 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific non-vascular stents market, 2014 - 2025 (USD Million)
5.4.2 Japan
5.4.2.1 Japan non-vascular stents market, 2014 - 2025 (USD Million)
5.4.3 China
5.4.3.1 China non-vascular stents market, 2014 - 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America non-vascular stents market, 2014 - 2025 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil non-vascular stents market, 2014 - 2025 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico non-vascular stents market, 2014 - 2025 (USD Million)
5.6 MEA
5.6.1 MEA non-vascular stents market, 2014 - 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa non-vascular stents market, 2014 - 2025 (USD Million)

Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 Company Profiles
6.3.1 Medtronic
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.2 C. R. Bard, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Boston Scientific Corporation
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 ELLA - CS, s.r.o.
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 CONMED Corporation
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.6 HOBBS MEDICAL INC
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.7 Cook Medical
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Taewoong Medical Co., Ltd.
6.3.8.1 Company overview
6.3.8.2 Product benchmarking
6.3.8.3 Strategic initiatives
6.3.9 Synchron Med Inc.
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Glaukos Corporation
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives

List of Tables

Table 1. Global cancer incidence, 2012
Table 2. Per capita health expenditure, USD, (2011-2014)
Table 3. List of market players
Table 4. North America non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 5. North America non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 6. North America non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 7. U.S. non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 8. U.S. non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 9. U.S. non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 10. Canada non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 11. Canada non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 12. Canada non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 13. Europe non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 14. Europe non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 15. Europe non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 16. UK non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 17. UK non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 18. UK non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 19. Germany non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 20. Germany non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 21. Germany non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 22. France non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 23. France non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 24. France non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 25. Italy non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 26. Italy non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 27. Italy non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 28. Spain non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 29. Spain non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 30. Spain non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 31. Asia Pacific non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 32. Asia Pacific non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 33. Asia Pacific non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 34. Japan non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 35. Japan non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 36. Japan non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 37. China non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 38. China non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 39. China non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 40. Latin America non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 41. Latin America non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 42. Latin America non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 43. Brazil non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 44. Brazil non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 45. Brazil non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 46. Mexico non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 47. Mexico non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 48. Mexico non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 49. MEA non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 50. MEA non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 51. MEA non-vascular pulmonary stents market, 2014 - 2025 (USD Million)
Table 52. South Africa non-vascular stents market, by product, 2014 - 2025 (USD Million)
Table 53. South Africa non-vascular gastrointestinal stents market, 2014 - 2025 (USD Million)
Table 54. South Africa non-vascular pulmonary stents market, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary, 2016 (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global geriatric population, 2012 - 2022 (Million)
FIG. 12 Global population by age group (Billion)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping
FIG. 15 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 16 Per capita healthcare spending, by country, 2016 (USD)
FIG. 17 Porter’s Five Forces analysis
FIG. 18 Non-vascular stents market product outlook: Key takeaways
FIG. 19 Non-vascular stents market: Product movement analysis
FIG. 20 Gastrointestinal stents market, 2014 - 2025 (USD Million)
FIG. 21 Biliary stents market, 2014 - 2025 (USD Million)
FIG. 22 Duodenal stents market, 2014 - 2025 (USD Million)
FIG. 23 Colonic stents market, 2014 - 2025 (USD Million)
FIG. 24 Pancreatic stents market, 2014 - 2025 (USD Million)
FIG. 25 Esophageal stents market, 2014 - 2025 (USD Million)
FIG. 26 Pulmonary (airway) stents market, 2014 - 2025 (USD Million)
FIG. 27 Silicone airway stents market, 2014 - 2025 (USD Million)
FIG. 28 Metallic airway stents market, 2014 - 2025 (USD Million)
FIG. 29 Urological stents market, 2014 - 2025 (USD Million)
FIG. 30 Others market, 2014 - 2025 (USD Million)
FIG. 31 Regional market place: Key takeaways
FIG. 32 Regional outlook, 2016 & 2025
FIG. 33 North America non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 34 U.S. non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 35 Canada non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 36 Europe non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 37 UK non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 38 Germany non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 39 France non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 40 Italy non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 41 Spain non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 42 Asia Pacific non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 43 Japan non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 44 China non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 45 Latin America non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 46 Brazil non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 47 Mexico non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 48 MEA non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 49 South Africa non-vascular stents market, 2014 - 2025 (USD Million)
FIG. 50 Strategy framework
FIG. 51 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • C. R. Bard, Inc.
  • Boston Scientific Corporation
  • ELLA - CS, s.r.o.
  • CONMED Corporation
  • HOBBS MEDICAL INC
  • Cook Medical
  • Taewoong Medical Co., Ltd.
  • Synchron Med Inc.
  • Glaukos Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll